59 research outputs found
Elastic Convection in Vibrated Viscoplastic Fluids
We observe a new type of behavior in a shear thinning yield stress fluid:
freestanding convection rolls driven by vertical oscillation. The convection
occurs without the constraint of container boundaries yet the diameter of the
rolls is spontaneously selected for a wide range of parameters. The transition
to the convecting state occurs without hysteresis when the amplitude of the
plate acceleration exceeds a critical value. We find that a non-dimensional
stress, the stress due to the inertia of the fluid normalized by the yield
stress, governs the onset of the convective motion.Comment: 4 pages, 6 figure
Comparisons of Therapeutic Effects of Allopurinol and Febuxostat in Chronic Hemodialysis Patients
More than few patients on maintenance hemodialysis present with hyperuricemia, and the control of serum uric acid level is an important issue in the long-term management. In addition to allopurinol, febuxostat can be used as a xanthine oxidase inhibitor in hemodialysis patients. In this study, the clinical effects of febuxostat were compared with allopurinol in chronic hemodialysis patients. Eligible hemodialysis patients taking allopurinol were randomly assigned to take 100 mg allopurinol(n=26)or 20 mg febuxostat(n=23)for 12 weeks. Serum uric acid was markedly lowered in the febuxostat group(0-week 6.7 mg/dL, 12-week 4.3 mg/dL, p<0.001)as compared with the allopurinol group(0-week 6.0 mg/dL, 12-week 5.8 mg/dL)and systolic blood pressure was lowered by 5 mmHg(p=0.036)at 4-week in the febuxostat group while blood pressure was not significantly changed in the allopurinol group throughout the study period. In addition, the dose of erythropoiesis stimulating agent was reduced(0-week 22.2 μg/wk, 12-week, 17.1 μg/wk, p=0.012)and serum phosphate level was lowered(0-week 5.9 mg/dL, 12-week 5.1 mg/dL, p=0.027)in the febuxostat group but not in the allopurinol group. It is concluded that febuxostat is more effective in lowering serum uric acid than allopurinol in hemodialysis patients. In addition, it is suggested that febuxostat has an advantage in the management of renal anemia and hyperphosphatemia as well as hyperuricemia
Comparisons of Increasing Calcium Channel Blocker dose and Adding Thiazide Diuretic in Hypertensive Patients Given Medium-dose Angiotensin II Receptor Blocker and Amlodipine
We compared the efficacies of 2 prescriptions, one of a medium-dose angiotensin II receptor blocker (ARB) with high-dose of calcium channel blocker (CCB) and another of medium-dose of ARB with medium-dose of CCB and a thiazide diuretic in 22 hypertensive patients who did not achieve the target blood pressure level with the combination of medium-dose of ARB and medium-dose of CCB. A randomized crossover study was performed giving a fixed combination of 100 mg irbesartan with 10 mg amlodipine or a fixed-dose combination of 100 mg irbesartan with 5 mg amlodipine added by 1 mg trichlormethiazide for 12-16 weeks each. The blood pressure measured in hospital was comparable between the high-dose CCB period (130/77 mmHg) and the thiazide period (130/79 mmHg). The morning and the evening blood pressures measured at home were also comparable in the high-dose of CCB and the thiazide periods, while the evening heart rate was higher in the thiazide period than in the high-dose CCB period. As for the laboratory data, hemoglobin A1c (+0.2%, p=0.013), serum nonHDL cholesterol (+12 mg/dL, p=0.047) and serum uric acid (+0.8 mg/dL, p=0.001) were significantly higher in the thiazide period than in the high-dose CCB period. On the other hand, urinary albumin excretion (-28.8%,p=0.026) and estimated glomerular filtration rate (-5.8%,p=0.012) were significantly lower in the thiazide period than in the high-dose CCB period. In the combination drug therapy of hypertension, the increase of CCB dose is preferable in preserving renal function and in avoiding adverse effects on metabolisms of glucose, lipid and uric acid
Upregulation of IGF-I in the goldfish retinal ganglion cells during the early stage of optic nerve regeneration
金沢大学医薬保健研究域 医学系Goldfish retinal ganglion cells (RGCs) can regrow their axons after optic nerve injury. However, the reason why goldfish RGCs can regenerate after nerve injury is largely unknown at the molecular level. To investigate regenerative properties of goldfish RGCs, we divided the RGC regeneration process into two components: (1) RGC survival, and (2) axonal elongation processes. To characterize the RGC survival signaling pathway after optic nerve injury, we investigated cell survival/death signals such as Bcl-2 family members in the goldfish retina. Amounts of phospho-Akt (p-Akt) and phospho-Bad (p-Bad) in the goldfish retina rapidly increased four- to five-fold at the protein level by 3-5 days after nerve injury. Subsequently, Bcl-2 levels increased 1.7-fold, accompanied by a slight reduction in caspase-3 activity 10-20 days after injury. Furthermore, level of insulin-like growth factor-I (IGF-I), which activates the phosphatidyl inositol-3-kinase (PI3K)/Akt system, increased 2-3 days earlier than that of p-Akt in the goldfish retina. The cellular localization of these molecular changes was limited to RGCs. IGF-I treatment significantly induced phosphorylation of Akt, and strikingly induced neurite outgrowth in the goldfish retina in vitro. On the contrary, addition of the PI3K inhibitor wortmannin, and IGF-I antibody inhibited Akt phosphorylation and neurite outgrowth in an explant culture. Thus, we demonstrated, for the first time, the signal cascade for early upregulation of IGF-I, leading to RGC survival and axonal regeneration in adult goldfish retinas through PI3K/Akt system after optic nerve injury. The present data strongly indicate that IGF-I is one of the most important molecules for controlling regeneration of RGCs after optic nerve injury. © 2007 Elsevier Ltd. All rights reserved
Subaru high-z exploration of low-luminosity quasars (SHELLQs). I. Discovery of 15 quasars and bright galaxies at 5.7 < z < 6.9
We report the discovery of 15 quasars and bright galaxies at 5.7 < z < 6.9.
This is the initial result from the Subaru High-z Exploration of Low-Luminosity
Quasars (SHELLQs) project, which exploits the exquisite multiband imaging data
produced by the Subaru Hyper Suprime-Cam (HSC) Strategic Program survey. The
candidate selection is performed by combining several photometric approaches
including a Bayesian probabilistic algorithm to reject stars and dwarfs. The
spectroscopic identification was carried out with the Gran Telescopio Canarias
and the Subaru Telescope for the first 80 deg2 of the survey footprint. The
success rate of our photometric selection is quite high, approaching 100 % at
the brighter magnitudes (zAB < 23.5 mag). Our selection also recovered all the
known high-z quasars on the HSC images. Among the 15 discovered objects, six
are likely quasars, while the other six with interstellar absorption lines and
in some cases narrow emission lines are likely bright Lyman-break galaxies. The
remaining three objects have weak continua and very strong and narrow Ly alpha
lines, which may be excited by ultraviolet light from both young stars and
quasars. These results indicate that we are starting to see the steep rise of
the luminosity function of z > 6 galaxies, compared with that of quasars, at
magnitudes fainter than M1450 ~ -22 mag or zAB ~24 mag. Follow-up studies of
the discovered objects as well as further survey observations are ongoing.Comment: Published in ApJ (828:26, 2016
Discovery of the First Low-Luminosity Quasar at z > 7
We report the discovery of a quasar at z = 7.07, which was selected from the
deep multi-band imaging data collected by the Hyper Suprime-Cam (HSC) Subaru
Strategic Program survey. This quasar, HSC J124353.93+010038.5, has an order of
magnitude lower luminosity than do the other known quasars at z > 7. The
rest-frame ultraviolet absolute magnitude is M1450 = -24.13 +/- 0.08 mag and
the bolometric luminosity is Lbol = (1.4 +/- 0.1) x 10^{46} erg/s. Its spectrum
in the optical to near-infrared shows strong emission lines, and shows evidence
for a fast gas outflow, as the C IV line is blueshifted and there is indication
of broad absorption lines. The Mg II-based black hole mass is Mbh = (3.3 +/-
2.0) x 10^8 Msun, thus indicating a moderate mass accretion rate with an
Eddington ratio 0.34 +/- 0.20. It is the first z > 7 quasar with sub-Eddington
accretion, besides being the third most distant quasar, known to date. The
luminosity and black hole mass are comparable to, or even lower than, those
measured for the majority of low-z quasars discovered by the Sloan Digital Sky
Survey, and thus this quasar likely represents a z > 7 counterpart to quasars
commonly observed in the low-z universe.Comment: Accepted for publication in ApJ Letter
Comparison between High-dose Telmisartan and Fixed dose Combination of Telmisartan and Hydrochlorothiazide in Patients with Hypertension
We compared treatment with a high-dose angiotensin II receptor blocker(ARB)and combination of ARB with a thiazide diuretic in 17 patients with hypertension. A randomized crossover study was performed giving 80 mg telmisartan or fixed-dose combination of 40 mg telmisartan and 12.5 mg hydrochlorothiazide for 16 weeks each. Although the clinic blood pressure was comparable between the high-dose ARB period(134/81 mmHg)and the combination period(134/82 mmHg), the morning home blood pressure was lower in the combination period than in the high-dose ARB period(138/82 vs. 151/88 mmHg, p=0.026/0.013). No significant difference was observed in urinary albumin excretion, but estimated glomerular filtration rate was lower in the combination than in the high-dose ARB period(58.9 vs. 62.1 mL/min/1.73 m^2, p=0.039). Serum uric acid was higher in the combination than in the high-dose ARB period(6.7 vs. 5.9 mg/dL p=0.022). The indices of glucose metabolism, serum lipids, oxidative stress, inflammation and adipocytokine did not significantly differ between the two periods. There was no significant difference in the measurement of endothelium-dependent vasodilation between the two periods. It is suggested that the addition of thiazide diuretic to medium-dose ARB is more effective in lengthening the hypotensive effect than high-dose ARB, however, care should be taken for the elevation of serum uric acid and the decrease in renal function
Protective Effects of Olmesartan and Azelnidipine against Cardiovascular Organ Injuries in Spontaneously Hypertensive Rats
In the treatment of hypertension, care should be taken for preventing of hypertensive organ injuries as well as lowering blood pressure to the adequate level in order to reduce the risk of cardiovascular diseases. The purpose of this study is to examine the effects of angiotensin II receptor blockers (ARB), calcium channel blockers (CCB) and their combination on the development of cardiovascular organ injuries in spontaneously hypertensive rats (SHR). Four groups of male 8-week-old SHR (n=9 each) were given vehicle(control), 10 mg/kg azelnidipine (AZL), 10 mg/kg olmesartan (OLM, n=9), or the combination of AZL and OLM(5 mg/kg each)for 12 weeks, and their effects on cardiovascular organ injuries were evaluated. Tail-cuff blood at 12 weeks was similarly lowered by AML, OLM and the combination therapy(148, 143 and 143 mmHg, respectively)as compared with the control SHR (198 mmHg). Pulse rate was significantly less in the AZL group but not in the OLM group or the combination therapy group than in the untreated control group (-27, -12, +6 bpm, respectively). The cardiac ventricular weight (AZL -12%, OLM -15%, combination -18% vs. control) and aortic thickness (AZL -17%, OLM -16%, combination -19% vs. control) were reduced by similar extents in the three groups given antihypertensive treatments. Regarding the myocardial fibrosis, left ventricular hydroxyproline content was reduced in the OLM and the combination groups but the change was not significant in the AZL group (AZL -14%,OLM -30%, combination -27% vs. control). In the echocardiographic evaluation of cardiac function, the index of left ventricular diastolic function is significantly improved in the OLM and the combination groups but not in the AZL group, while the index of systolic function was not different between the four groups. It is suggested that the antihypertensive therapy including ARB is superior to the monotherapy by CCB in preventing the myocardial fibrosis and preserving the left ventricular diastolic function
First Data Release of the Hyper Suprime-Cam Subaru Strategic Program
The Hyper Suprime-Cam Subaru Strategic Program (HSC-SSP) is a three-layered
imaging survey aimed at addressing some of the most outstanding questions in
astronomy today, including the nature of dark matter and dark energy. The
survey has been awarded 300 nights of observing time at the Subaru Telescope
and it started in March 2014. This paper presents the first public data release
of HSC-SSP. This release includes data taken in the first 1.7 years of
observations (61.5 nights) and each of the Wide, Deep, and UltraDeep layers
covers about 108, 26, and 4 square degrees down to depths of i~26.4, ~26.5, and
~27.0 mag, respectively (5sigma for point sources). All the layers are observed
in five broad bands (grizy), and the Deep and UltraDeep layers are observed in
narrow bands as well. We achieve an impressive image quality of 0.6 arcsec in
the i-band in the Wide layer. We show that we achieve 1-2 per cent PSF
photometry (rms) both internally and externally (against Pan-STARRS1), and ~10
mas and 40 mas internal and external astrometric accuracy, respectively. Both
the calibrated images and catalogs are made available to the community through
dedicated user interfaces and database servers. In addition to the pipeline
products, we also provide value-added products such as photometric redshifts
and a collection of public spectroscopic redshifts. Detailed descriptions of
all the data can be found online. The data release website is
https://hsc-release.mtk.nao.ac.jp/.Comment: 34 pages, 20 figures, 7 tables, moderate revision, accepted for
publication in PAS
- …